FDA Class I Recall on Lifepak CR Plus AED

Here is important info on the Lifepak CR Plus AED recall. The info below is from the FDA website:

Physio-Control Inc., LIFEPAK CR Plus Automated External Defibrillators (AEDs)

Recall Class:	Class I
Date Recall Initiated:	July 31, 2009
Product:	Physio-Control Inc., LIFEPAK CR Plus Automated External Defibrillator (AED) Only the Physio-Control LIFEPAK CR PLUS AEDs with the serial numbers below are affected by this recall. Serial Numbers 37026963, 37026983, 37026984, 37026997, 37027002 37027008, 37027039, 37027040, 37027049, 37027053 37027063, 37027065, 37027066, 37027070, 37027071 37027073, 37027075, 37027090, 37027099, 37027105 37027122, 37027197, 37027529, 37027569, 37031393 37037850, 37037893, 37037986, 37038002, 37038211 37038365, 37135986, 37154526, 37154638 The serial number is located on the underside of the device. The AEDs were manufactured and distributed from July 9, 2008 through August 19, 2008.
Use:	This device is used by emergency or medical personnel, by others who have completed CPR AED training courses, or the public at large. It is intended to treat patients in cardiac arrest. The device analyzes an unconscious patient’s heart rhythm and instructs the user to press a button that delivers an electrical shock to the heart to restore a normal heart rhythm.
Recalling Firm:	Physio-Control, Inc. 11811 Willows Road NE Redmond, Washington 98052-2003
Reason for Recall:	An extremely humid environment may cause the LIFEPAK CR Plus AED to improperly analyze the rhythm correctly and may cause the device to delay or fail to delivery therapy.
Public Contact:	Physio-Control Customer Care 1-800-442-1142, 6 AM through 4 PM Pacific Time
FDA District:	Seattle
FDA Comments:	Physio-Control called their customers from August 18-19, 2009 with a follow-up email message on August 20, 2009. The company sent replacements on August 19, 2009. Class I recalls are the most serious type of recall and involve situations in which there is a reasonable probability that use of these products will cause serious injury or death. Health care professionals and consumers may report adverse reactions or quality problems experienced with the use of these products to the FDA’s MedWatch Adverse Event Reporting Program either online, by regular mail or by FAX.